AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · IEX Real-Time Price · USD
0.440
-0.042 (-8.73%)
Dec 29, 2023, 4:00 PM EST - Market closed
AIM ImmunoTech Market Cap
AIM ImmunoTech has a market cap or net worth of $21.49 million as of December 29, 2023. Its market cap has increased by 27.89% in one year.
Market Cap
21.49M
Enterprise Value
-195.54K
1-Year Change
27.89%
Ranking
Category
Stock Price
$0.44
Market Cap Chart
Since December 1, 1998, AIM ImmunoTech's market cap has decreased from $159.00M to $21.49M, a decrease of -86.49%. That is a compound annual growth rate of -7.67%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 29, 2023 | 21.50M | -8.51% |
Dec 28, 2023 | 23.50M | -2.49% |
Dec 27, 2023 | 24.10M | -2.43% |
Dec 26, 2023 | 24.70M | 4.22% |
Dec 22, 2023 | 23.70M | 1.28% |
Dec 21, 2023 | 23.40M | -1.27% |
Dec 20, 2023 | 23.70M | -2.87% |
Dec 19, 2023 | 24.40M | 6.09% |
Dec 18, 2023 | 23.00M | -0.43% |
Dec 15, 2023 | 23.10M | -9.77% |
Dec 14, 2023 | 25.60M | 0.79% |
Dec 13, 2023 | 25.40M | 6.28% |
Dec 12, 2023 | 23.90M | -3.24% |
Dec 11, 2023 | 24.70M | -9.52% |
Dec 8, 2023 | 27.30M | -0.36% |
Dec 7, 2023 | 27.40M | 11.84% |
Dec 6, 2023 | 24.50M | 6.06% |
Dec 5, 2023 | 23.10M | 5.00% |
Dec 4, 2023 | 22.00M | -5.98% |
Dec 1, 2023 | 23.40M | 1.74% |
Nov 30, 2023 | 23.00M | -0.43% |
Nov 29, 2023 | 23.10M | 7.44% |
Nov 28, 2023 | 21.50M | 3.37% |
Nov 27, 2023 | 20.80M | -0.95% |
Nov 24, 2023 | 21.00M | 0.96% |
View and export this data all the way back to 1998.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Virax Biolabs Group | 22.70M |
Ocean Biomedical | 22.45M |
Lisata Therapeutics | 22.22M |
Viracta Therapeutics | 22.02M |
ProMIS Neurosciences | 21.72M |
Protara Therapeutics | 21.31M |
Femasys | 21.11M |
NLS Pharmaceutics AG | 21.04M |